Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sargramostim for Mucositis in Head and Neck Cancer Patients Receiving Radiation Therapy
NCT00008398Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Oct 2000
- Primary completion
- Mar 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of sargramostim in oral mucositis (OM), sponsored by NRG Oncology. Started Oct 2000; status: completed.
02
Drugs
sargramostim
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00008398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008398.